Loading resource…

Division of Clinical Pharmacology & Toxicology, University Hospital Basel; Max Zeller Sohne Ltd; CNRS, INSERM, Institut Cochin, Université Paris Cité; Epatocentro Ticino
The article provides a comprehensive review of metformin, detailing its role in glucose metabolism through various pathways including gluconeogenesis and glycolysis. It discusses the pharmacokinetics of metformin, including its absorption, distribution, and elimination in the body. Additionally, the review highlights clinical studies that investigate the glucose-lowering effects of metformin in patients with type 2 diabetes and prediabetes, as well as its historical and current clinical use.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology

2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology

SYNDROME OF INAPPROPRIATE ANTIDIURESIS: FROM PATHOPHYSIOLOGY TO MANAGEMENT
Same clinical topic · Endocrinology

GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology

DIAGNOSIS AND MANAGEMENT OF CENTRAL DIABETES INSIPIDUS IN ADULTS
Same clinical topic · Endocrinology

ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology

DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology

OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology

ROLE OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN ACHIEVING WEIGHT LOSS AND IMPROVING CARDIOVASCULAR OUTCOMES IN PEOPLE WITH OVERWEIGHT AND OBESITY
Same clinical topic · Endocrinology